Quality by design endorsed atorvastatin-loaded nanostructured lipid carriers embedded in pH-responsive gel for melanoma

References

• Abdelaal, M.Y., et al., 2007. Chitosan-based interpolymeric pH-responsive hydrogels for in vitro drug release. Journal of applied polymer science, 103 (5), 2864–2874. doi: 10.1002/app.25154.
   Web of Science ®Google Scholar
• Alam, T., et al., 2015. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert opinion on drug delivery, 12 (2), 181–194. doi: 10.1517/17425247.2014.945416.
   PubMed Web of Science ®Google Scholar
• Alt, N., et al., 2016. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals, 44 (5), 291–305. doi: 10.1016/j.biologicals.2016.06.005.
   PubMed Web of Science ®Google Scholar
• Arora, A., et al., 2020. Intranasal delivery of tetrabenazine nanoemulsion via olfactory region for better treatment of hyperkinetic movement associated with Huntington’s disease: Pharmacokinetic and brain delivery study. Chemistry and physics of lipids, 230, 104917. doi: 10.1016/j.chemphyslip.2020.104917.
   PubMed Web of Science ®Google Scholar
• Augustine, R., 2018. Skin bioprinting: a novel approach for creating artificial skin from synthetic and natural building blocks. Progress in biomaterials, 7 (2), 77–92. doi: 10.1007/s40204-018-0087-0.
   PubMed Web of Science ®Google Scholar
• Aven, T., 2016. Risk assessment and risk management: review of recent advances on their foundation. European journal of operational research, 253 (1), 1–13. doi: 10.1016/j.ejor.2015.12.023.
   Web of Science ®Google Scholar
• Bagasariya, D., et al., 2022. Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma. European journal of pharmaceutics and biopharmaceutics, 177, 157–174. doi: 10.1016/j.ejpb.2022.06.014.
   PubMed Web of Science ®Google Scholar
• Barakat, L., et al., 2013. Comparison of efficacy and safety of rosuvastatin, atorvastatin and pravastatin among dyslipidemic diabetic patients. ISRN pharmacology, 2013, 146579–146577. doi: 10.1155/2013/146579.
   PubMedGoogle Scholar
• Budianto, E., Muthoharoh, S.P., and Nizardo, N.M., 2015. Effect of crosslinking agents, pH and temperature on swelling behavior of cross-linked chitosan hydrogel. Asian journal of applied sciences, 3 (5), 2321–0893.
   Google Scholar
• Chand, P., et al., 2021. Design and evaluation of cabazitaxel loaded NLCs against breast cancer cell lines. Colloids and surfaces, 199, 111535. doi: 10.1016/j.colsurfb.2020.111535.
   Google Scholar
• Charankumar, K., et al., 2023. Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma. Journal of drug delivery science and technology, 84, 104453. doi: 10.1016/j.jddst.2023.104453.
   Web of Science ®Google Scholar
• Chaudhari, V.S., et al., 2021. Quercetin and piperine enriched nanostructured lipid carriers (NLCs) to improve apoptosis in oral squamous cellular carcinoma (FaDu cells) with improved biodistribution profile. European journal of pharmacology, 909, 174400. doi: 10.1016/j.ejphar.2021.174400.
   PubMed Web of Science ®Google Scholar
• Comito, F., et al., 2022. Emerging Novel Therapeutic Approaches for Treatment of Advanced Cutaneous Melanoma. Cancers, 14 (2), 271. doi: 10.3390/cancers14020271.
   PubMed Web of Science ®Google Scholar
• Costa, C.P., et al., 2021. Quality by design (QbD) optimization of diazepam-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery: toxicological effect of surface charge on human neuronal cells. International journal of pharmaceutics, 607, 120933. doi: 10.1016/j.ijpharm.2021.120933.
   PubMed Web of Science ®Google Scholar
• Culbertson, A., and Huey, S., 2022. Recognizing recurrence of melanoma in an emergency department patient: a case study. Advanced emergency nursing journal, 44 (2), 109–115. doi: 10.1097/TME.0000000000000402.
   PubMed Web of Science ®Google Scholar
• Daniel, B., and DeCoster, M.A., 2004. Quantification of sPLA2-induced early and late apoptosis changes in neuronal cell cultures using combined TUNEL and DAPI staining. Brain research, 13 (3), 144–150. doi: 10.1016/j.brainresprot.2004.04.001.
   Web of Science ®Google Scholar
• Delgado, D., et al., 2011. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway. European journal of pharmaceutics and biopharmaceutics, 79 (3), 495–502. doi: 10.1016/j.ejpb.2011.06.005.
   PubMed Web of Science ®Google Scholar
• Demierre, M.F., et al., 2005. Statins and cancer prevention. Nature reviews. Cancer, 5 (12), 930–942. doi: 10.1038/nrc1751.
   PubMed Web of Science ®Google Scholar
• Famta, P., et al., 2022a. Quality by design (QbD) assisted fabrication & evaluation of simvastatin loaded nano-enabled thermogel for melanoma therapy. International journal of pharmaceutics, 628, 122270. doi: 10.1016/j.ijpharm.2022.122270.
   PubMed Web of Science ®Google Scholar
• Famta, P., et al., 2022b. Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer. Life sciences, 310, 121125. doi: 10.1016/j.lfs.2022.121125.
   PubMed Web of Science ®Google Scholar
• Famta, P., et al., 2023. Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia. European journal of pharmaceutics and biopharmaceutics, 190, 94–106. doi: 10.1016/j.ejpb.2023.07.008.
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz, C., Morales, A., and Fernandez-Checa, J.C., 2012. Statins and protein prenylation in cancer cell biology and therapy. Anti-cancer agents in medicinal chemistry, 12 (4), 303–315. doi: 10.2174/187152012800228715.
   PubMed Web of Science ®Google Scholar
• Garg, N.K., et al., 2017. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): an improved dermatokinetic profile for inflammatory disorder(s). International journal of pharmaceutics, 517 (1-2), 413–431. doi: 10.1016/j.ijpharm.2016.12.010.
   PubMed Web of Science ®Google Scholar
• Ghasemiyeh, P., and Mohammadi-Samani, S., 2018. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Research in pharmaceutical sciences, 13 (4), 288–303. doi: 10.4103/1735-5362.235156.
   PubMed Web of Science ®Google Scholar
• Gilani, S.J., et al., 2021. Chitosan coated luteolin nanostructured lipid carriers: optimization, in vitro-ex vivo assessments and cytotoxicity study in breast cancer cells. Coatings, 11 (2), 158. doi: 10.3390/coatings11020158.
   Web of Science ®Google Scholar
• Grela, E., Kozłowska, J., and Grabowiecka, A., 2018. Current methodology of MTT assay in bacteria – A review. Acta histochemica, 120 (4), 303–311. doi: 10.1016/j.acthis.2018.03.007.
   PubMed Web of Science ®Google Scholar
• Hu, T., et al., 2020. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling. Anti-cancer drugs, 31 (4), 377–384. doi: 10.1097/CAD.0000000000000885.
   PubMed Web of Science ®Google Scholar
• Huang, A.C., and Zappasodi, R., 2022. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance. Nature immunology, 23 (5), 660–670. doi: 10.1038/s41590-022-01141-1.
   PubMed Web of Science ®Google Scholar
• Istvan, E.S., and Deisenhofer, J., 2001. Structural mechanism for statin inhibition of HMG-CoA reductase. Science, 292 (5519), 1160–1164. doi: 10.1126/science.1059344.
   PubMed Web of Science ®Google Scholar
• Jain, K., Sood, S., and Gowthamarajan, K., 2015. Optimization of artemether-loaded NLC for intranasal delivery using central composite design. Drug delivery, 22 (7), 940–954. doi: 10.3109/10717544.2014.885999.
   PubMed Web of Science ®Google Scholar
• Javed, M.N., et al., 2019. QbD applications for the development of nanopharmaceutical products. In: S. Beg and S. Hasnain, eds. Pharmaceutical quality by design: Principles and applications. Amsterdam: Elsevier, 229–253.
   Google Scholar
• Konstantinopoulos, P.A., Karamouzis, M.V., and Papavassiliou, A.G., 2007. Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nature reviews drug discovery, 6 (7), 541–555. doi: 10.1038/nrd2221.
   PubMed Web of Science ®Google Scholar
• Mahmood, A., et al., 2021. Luliconazole loaded lyotropic liquid crystalline nanoparticles for topical delivery: QbD driven optimization, in-vitro characterization and dermatokinetic assessment. Chemistry and physics of lipids, 234, 105028. doi: 10.1016/j.chemphyslip.2020.105028.
   PubMed Web of Science ®Google Scholar
• Namjoshi, S., et al., 2020. Quality by design: development of the quality target product profile (QTPP) for semisolid topical products. Pharmaceutics, 12 (3), 287. doi: 10.3390/pharmaceutics12030287.
   PubMed Web of Science ®Google Scholar
• Oishi, T., et al., 2020. Creation of novel large dataset comprising several granulation methods and the prediction of tablet properties from critical material attributes and critical process parameters using regularized linear regression models including interaction terms. International journal of pharmaceutics, 577, 119083. doi: 10.1016/j.ijpharm.2020.119083.
   PubMed Web of Science ®Google Scholar
• Patel, D., et al., 2012. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in vivo evaluation. Scientia pharmaceutica, 80 (3), 749–764. doi: 10.3797/scipharm.1202-12.
   PubMedGoogle Scholar
• Prabhu, P., and Patravale, V., 2016. Dissolution enhancement of atorvastatin calcium by co-grinding technique. Drug delivery and translational research, 6 (4), 380–391. doi: 10.1007/s13346-015-0271-x.
   PubMed Web of Science ®Google Scholar
• Pramod, K., et al., 2016. Pharmaceutical product development: a quality by design approach. International journal of pharmaceutical investigation, 6 (3), 129–138. doi: 10.4103/2230-973X.187350.
   PubMed Web of Science ®Google Scholar
• Pushpakom, S., et al., 2019. Drug repurposing: progress, challenges and recommendations. Nature reviews. Drug discovery, 18 (1), 41–58. 1doi: 10.1038/nrd.2018.168.
   PubMed Web of Science ®Google Scholar
• Raina, H., Kaur, S., and Jindal, A.B., 2017. Development of efavirenz loaded solid lipid nanoparticles: risk assessment, quality-by-design (QbD) based optimisation and physicochemical characterisation. Journal of drug delivery science and technology, 39, 180–191. doi: 10.1016/j.jddst.2017.02.013.
   Web of Science ®Google Scholar
• Rangaraj, N., et al., 2020. QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach. Drug delivery and translational research, 10 (5), 1476–1494. doi: 10.1007/s13346-020-00803-7.
   PubMed Web of Science ®Google Scholar
• Resh, M.D., 1996. Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins. Cellular signalling, 8 (6), 403–412. doi: 10.1016/s0898-6568(96)00088-5.
   PubMed Web of Science ®Google Scholar
• Rogala, P., et al., 2022. Long-term outcomes of targeted therapy after first-line immunotherapy in braf-mutated advanced cutaneous melanoma Patients-Real-World Evidence. Journal of clinical medicine, 11 (8), 2239. doi: 10.3390/jcm11082239.
   PubMed Web of Science ®Google Scholar
• Sabzichi, M., et al., 2017. Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway. Process biochemistry, 60, 84–91. doi: 10.1016/j.procbio.2017.05.024.
   Web of Science ®Google Scholar
• Sahu, P., et al., 2019. pH triggered and charge attracted nanogel for simultaneous evaluation of penetration and toxicity against skin cancer: In-vitro and ex-vivo study. International journal of biological macromolecules, 128, 740–751. doi: 10.1016/j.ijbiomac.2019.01.147.
   PubMed Web of Science ®Google Scholar
• Sakellari, G.I., et al., 2021. Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active. Food hydrocolloids for health, 1, 100024. doi: 10.1016/j.fhfh.2021.100024.
   Google Scholar
• Shah, S., et al., 2022. Quality by design steered development of Niclosamide loaded liposomal thermogel for melanoma: in vitro and ex vivo evaluation. European journal of pharmaceutics and biopharmaceutics, 180, 119–136. doi: 10.1016/j.ejpb.2022.09.024.
   PubMed Web of Science ®Google Scholar
• Shah, S., et al., 2023. Quality by design accredited self-nanoemulsifying delivery of ibrutinib for extenuating the fast-fed variability, ameliorating the anticancer activity and oral bioavailability in prostate cancer. Journal of drug delivery science and technology, 89, 105052. doi: 10.1016/j.jddst.2023.105052.
   Web of Science ®Google Scholar
• Shekhar Maurya, C., and Sarkar, C., 2022. Characterization of highly stable water-based magnetorheological gel using OPTIGEL-WX as an additive: the study of magneto-induced rheological and viscoelastic properties. Journal of industrial and engineering chemistry, 110, 137–149. doi: 10.1016/j.jiec.2022.02.043.
   Web of Science ®Google Scholar
• Singh, A., et al., 2006. External stimuli response on a novel chitosan hydrogel crosslinked with formaldehyde. Bulletin of materials science, 29 (3), 233–238. doi: 10.1007/BF02706490.
   Web of Science ®Google Scholar
• Sleire, L., et al., 2017. Drug repurposing in cancer. Pharmacological research, 124, 74–91. doi: 10.1016/j.phrs.2017.07.013.
   PubMed Web of Science ®Google Scholar
• Sreelatha, T., Subramanyam, M.V., and Prasad, M.N.G., 2019. Early detection of skin cancer using melanoma segmentation technique. Journal of medical systems, 43 (7), 190. doi: 10.1007/s10916-019-1334-1.
   PubMedGoogle Scholar
• Switzer, B., et al., 2022. Managing metastatic melanoma in 2022: a clinical review. JCO oncology practice, 18 (5), 335–351. doi: 10.1200/OP.21.00686.
   PubMedGoogle Scholar
• Theodosakis, N., et al., 2019. Inhibition of isoprenylation synergizes with MAPK blockade to prevent growth in treatment-resistant melanoma, colorectal, and lung cancer. Pigment cell & melanoma research, 32 (2), 292–302. doi: 10.1111/pcmr.12742.
   PubMed Web of Science ®Google Scholar
• Tyndall, A., Du, W., and Breder, C.D., 2017. Regulatory watch: The target product profile as a tool for regulatory communication: advantageous but underused. Nature reviews drug discovery, 16 (3), 156–156. doi: 10.1038/nrd.2016.264.
   PubMed Web of Science ®Google Scholar
• van Meerloo, J., Kaspers, G.J.L., and Cloos, J., 2011. Cell sensitivity assays: the MTT assay. Methods in molecular biology, 731, 237–245. doi: 10.1007/978-1-61779-080-5_20.
   PubMedGoogle Scholar
• Vitorino, C., et al., 2020. QbD-driven development of intranasal lipid nanoparticles for depression treatment. European journal of pharmaceutics and biopharmaceutics, 153, 106–120. doi: 10.1016/j.ejpb.2020.04.011.
   PubMed Web of Science ®Google Scholar
• Wu, L., et al., 2020. Repaglinide-loaded nanostructured lipid carriers with different particle sizes for improving oral absorption: preparation, characterization, pharmacokinetics, and in situ intestinal perfusion. Drug delivery, 27 (1), 400–409. doi: 10.1080/10717544.2019.1689313.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., et al., 2020. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal transduction and targeted therapy, 5 (1), 113. doi: 10.1038/s41392-020-00213-8.
   PubMed Web of Science ®Google Scholar